AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26187303
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care arm (standard clinic care for insulin titration)
Trial: 26187303
Drug: Mobile Insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mobile Insulin Titration Intervention (MITI)
Trial: 6336975
Drug: Allopurinol pretreatment
RxNorm normalized name: Allopurinol
DrugBank: Allopurinol (DB00437)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Allopurinol pretreatment (300 mg two hours prior to and 10 hours after 5-FU)
Trial: 6336975
Drug: Allopurinol pretreatment
RxNorm normalized name: Allopurinol
DrugBank: Allopurinol (DB00437)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Allopurinol pretreatment (300 mg every 8 hours for 4 doses starting 24 hours before 5-FU)
Trial: 6336975
Drug: 5-FU administration
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-FU administration
Trial: 23622444
Drug: Conventionally managed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventionally managed eyes (treatment only if threshold ROP developed)
Trial: 20725062
Drug: EGCG (Teavigo)
RxNorm normalized name: EGCG
DrugBank: Epigallocatechin gallate (DB12116)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EGCG (Teavigo) 135 mg/capsule, 3 capsules/day for 48 hours
Trial: 11733254
Drug: Dexamethasone eyedrops
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone eyedrops (0.1%) four times daily for 4 weeks (group A)
Trial: 9441102
Drug: KRM 1648
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KRM 1648 (KRM) at 20 micrograms/ml
Trial: 9441102
Drug: Rifabutin (RBT)
RxNorm normalized name: Rifabutin
DrugBank: Rifabutin (DB00615)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rifabutin (RBT) at 20 micrograms/ml
Trial: 9441102
Drug: KRM 1648
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KRM 1648 (KRM) at 0.2 microgram/ml combined with 2.0 micrograms/ml of CLA
Trial: 9441102
Drug: Rifabutin (RBT)
RxNorm normalized name: Rifabutin
DrugBank: Rifabutin (DB00615)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rifabutin (RBT) at 0.2 microgram/ml combined with 2.0 micrograms/ml of CLA
Trial: 7950502
Drug: Ipriflavone (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipriflavone (600 mg/day, tdd) with 500 mg/day of calcium
Trial: 2888551
Drug: Thyrotrophin binding
RxNorm normalized name: Thyrotropin
DrugBank: Thyrotropin (DB15263)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyrotrophin binding inhibiting (TBII) antibodies
Trial: 2888551
Drug: Thyroid stimulating
RxNorm normalized name: Thyroid stimulating hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyroid stimulating (TSAb) antibodies
Trial: 2888551
Drug: Thyroid growth
RxNorm normalized name: Thyroid growth-promoting immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyroid growth stimulating (TGI) antibodies
Trial: 26292908
Drug: POCT urine
RxNorm normalized name: Urin DS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: POCT urine culture and susceptibility testing and targeted treatment
Trial: 26292908
Drug: POCT urine
RxNorm normalized name: Urin DS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: POCT urine culture without susceptibility testing and empirical treatment
Trial: 23811325
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment involving no sleep restriction but a fixed sleep schedule for older average sleepers.
Trial: 21399490
Drug: Propofol (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (4 mg · kg⁻¹ · h⁻¹)
Trial: 16837678
Drug: Doxycycline (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline (200 mg on the first day, then 100 mg per day for four days)
Trial: 9036434
Drug: 21-G pencil-point
RxNorm normalized name: ferric subsulfate solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 21-G pencil-point needle (Sprotte)
Trial: 9036434
Drug: 22-G Quincke
RxNorm normalized name: zinc oxide
DrugBank: Zinc oxide (DB09321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 22-G Quincke needle
Trial: 3887210
Drug: Platelet antiaggregant
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet antiaggregant therapy
Trial: 7284544
Drug: Experimental treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental treatment (not specified)
Trial: 20081560
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment for spinal stenosis
Trial: 25365713
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment for degenerative spondylolisthesis (DS)
Trial: 25365713
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment for intervertebral disc herniation (IDH)
Trial: 25365713
Drug: Nonoperative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonoperative treatment for degenerative spondylolisthesis (DS)
Trial: 25365713
Drug: Nonoperative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonoperative treatment for intervertebral disc herniation (IDH)
Trial: 12222716
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam sedation
Trial: 12222716
Drug: Rectal midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Rectal midazolam sedation
Trial: 7734163
Drug: Prophylactic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic therapy with amoxicillin and clavulanic acid for 24 hours
Trial: 7734163
Drug: Prophylactic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic therapy with amoxicillin and clavulanic acid for 5 days
Trial: 7004556
Drug: Paracetamol/dextropropoxyphene combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol/dextropropoxyphene combination
Trial: 27015801
Drug: Nasal high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal high flow (NHF) at 30 L/min
Trial: 27015801
Drug: Long-term oxygen
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term oxygen therapy (LTOT) at 2‐4 L/min
Trial: 18256366
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (blood pressure lowering regimen)
Trial: 2643188
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of 2 grams of ampicillin at the site of incision at closure
Trial: 2643188
Drug: No topical
RxNorm normalized name: Altreno Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No topical application of ampicillin
Trial: 2643188
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of ampicillin
Trial: 377739
Drug: Aspirin 2.4
RxNorm normalized name: oxycodone/aspirin 2.44 mg-325 mg ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 2.4 g daily
Trial: 377739
Drug: Allopurinol 200
RxNorm normalized name: allopurinol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol 200 mg daily
Trial: 24684456
Drug: Chewable tablet
RxNorm normalized name: Chewable Tablet
DrugBank: Bismuth subsalicylate (DB01294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chewable tablet (TAB)
Trial: 19120740
Drug: Interpersonal social
RxNorm normalized name: Safety 1st Social Safety Pack KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interpersonal social rhythm therapy
Trial: 15117896
Drug: Metformin (1.5-2.55
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (1.5-2.55 g/day)
Trial: 11985913
Drug: Beraprost sodium
RxNorm normalized name: beraprost sodium
DrugBank: Beraprost (DB05229)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beraprost sodium (median dose 80 microg four times a day)
Trial: 7898228
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg twice daily (with triple therapy)
Trial: 7898228
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy without omeprazole
Trial: 27549867
Drug: Dutasteride 0.5
RxNorm normalized name: dutasteride 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride 0.5 mg daily for 24 weeks
Trial: 27549867
Drug: Finasteride 1
RxNorm normalized name: finasteride 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride 1 mg daily for 24 weeks
Trial: 23605225
Drug: Neurofeedback treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neurofeedback treatment (30 sessions)
Trial: 23605225
Drug: Usual maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual maintenance treatment (Methadone or Buprenorphine)
Trial: 19626391
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (3 mg/kg and 10 mg/kg infliximab)
Trial: 17605449
Drug: Sham procedure
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Sham procedure (heel preparation with no heel puncture)
Trial: 30168731
Drug: Sildenafil (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (50 mg acute dose)
Trial: 30168731
Drug: Sildenafil (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (20 mg/day for 4 weeks)
Trial: 28031082
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose alendronate (70 mg per two weeks)
Trial: 28031082
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose alendronate (70 mg weekly)
Trial: 28031082
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose and standard dose alendronate
Trial: 20685525
Drug: Extraction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extraction therapy (4 premolar extractions)
Trial: 20685525
Drug: Nonextraction treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonextraction treatment with air-rotor stripping (ARS)
Trial: 17995982
Drug: PRP plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP plus intravitreal injection of 1.5 mg of bevacizumab
Trial: 12813449
Drug: rhTPO 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhTPO 1.5 microg/kg on days 1, 3, and 5 before G-CSF
Trial: 12813449
Drug: rhTPO 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhTPO 0.5 microg/kg on all 3 treatment days
Trial: 12813449
Drug: rhTPO treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhTPO treatment
Trial: 12813449
Drug: Placebo on
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo on days 1, 3, and 5 with G-CSF 5 microg/kg/day
Trial: 7474048
Drug: Biofeedback (with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biofeedback (with all treatment groups)
Trial: 6755768
Drug: Furosemide 40
RxNorm normalized name: furosemide 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide 40 mg at 07h00, 13h00, and 19h00
Trial: 26646464
Drug: Overall extracorporeal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall extracorporeal membrane oxygenation therapy
Trial: 23572490
Drug: Acetylcysteine 1200
RxNorm normalized name: acetylcysteine 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetylcysteine 1200 mg
Trial: 20617358
Drug: Tocilizumab (TCZ)
RxNorm normalized name: Tocilizumab
DrugBank: Tocilizumab (DB06273)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tocilizumab (TCZ) treatment for 24 weeks
Trial: 2620952
Drug: 1.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg/kg succinylcholine
Trial: 16368821
Drug: 2.0 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 mg/kg succinylcholine
Trial: 16368821
Drug: saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: saline solution (control group)
Trial: 10678346
Drug: Lignocaine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lignocaine (10 mg) and methylprednisolone (40 mg) injection
Trial: 10678346
Drug: Lignocaine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lignocaine (10 mg) injection only
Trial: 3524471
Drug: Intralesional alpha
RxNorm normalized name: alpha tocopherol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional alpha 2-interferon (IFN) 5 X 10(5) IU per dose, nine injections
Trial: 3524471
Drug: Intralesional alpha
RxNorm normalized name: alpha tocopherol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional alpha 2-interferon (IFN) 1 X 10(5) IU per injection
Trial: 3524471
Drug: Intralesional alpha
RxNorm normalized name: alpha tocopherol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional alpha 2-interferon (IFN) 1 X 10(4) IU per injection
Trial: 3524471
Drug: Intralesional alpha
RxNorm normalized name: alpha tocopherol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional alpha 2-interferon (IFN) 5 X 10(5) IU per injection, minimum of six injections
Trial: 31679866
Drug: Zoster Vaccine
RxNorm normalized name: ZOSTER VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zoster Vaccine Live (ZVL)
Trial: 27778367
Drug: GR-MD-02 (galectin-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GR-MD-02 (galectin-3 inhibitor)
Trial: 21056263
Drug: Zoledronic Acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic Acid (ZOL) 4 mg
Trial: 17444041
Drug: PPV combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPV combined with intravitreous antibiotic drugs
Trial: 10215750
Drug: Ceftibuten (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftibuten (9 mg kg(‐1))
Trial: 10215750
Drug: Cefixime (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime (8 mg kg(‐1))
Trial: 10215750
Drug: Azithromycin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (10 mg kg(‐1))
Trial: 8885951
Drug: Low-dose indomethacin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose indomethacin
Trial: 1950147
Drug: Cocktail group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocktail group (100 ml of fluorescein mixture)
Trial: 1950147
Drug: Fraction group
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fraction group (10 ml isolated fluorescein)
Trial: 26121495
Drug: d-cycloserine (DCS)
RxNorm normalized name: D-Cycloserine
DrugBank: Cycloserine (DB00260)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: d-cycloserine (DCS) 50 mg
Trial: 22779378
Drug: Oral health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health education interventions (sample bag and/or video)
Trial: 12447338
Drug: Standard oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard oxygen treatment
Trial: 12479025
Drug: Seroxat 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seroxat 20 mg daily for four weeks
Trial: 12479025
Drug: Post-treatment observation
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Post-treatment observation after stopping Seroxat
Trial: 9805695
Drug: Epidural fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Epidural fentanyl with 0.5% lidocaine (Group L + F) at doses of 0, 0.3, 1, 3, and 5 micrograms/kg
Trial: 9805695
Drug: Epidural fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Epidural fentanyl alone (Group F) at doses of 1, 3, and 5 micrograms/kg
Trial: 7714348
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg controlled-release morphine sulfate tablet
Trial: 7714348
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg controlled-release morphine sulfate tablet
Trial: 1524367
Drug: 100 micrograms/ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 micrograms/ml rPDGF-BB
Trial: 31667483
Drug: Crocetin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crocetin (10 mg per day)
Trial: 22036839
Drug: ICP-targeted therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICP-targeted therapy with CM monitoring
Trial: 22036839
Drug: CPP-targeted therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPP-targeted therapy
Trial: 22036839
Drug: ICP-targeted therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICP-targeted therapy
Trial: 19131241
Drug: Gastrazole by
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastrazole by continuous intravenous infusion
Trial: 17994402
Drug: Levalbuterol HFA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levalbuterol HFA 90 microg (two actuations of 45 microg) administered via metered dose inhaler (MDI) 30 minutes before exercise
Trial: 17994402
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered via metered dose inhaler (MDI) 30 minutes before exercise
Trial: 12494136
Drug: Antihypertensive drugs
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive drugs (all 4 main classes)
Trial: 9876338
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg daily dose of DHEA for 6 months
Trial: 10878680
Drug: Dexfenfluramine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexfenfluramine (30 mg/day)
Trial: 2536868
Drug: Adjuvant surgical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant surgical resection after chemotherapy
Trial: 28235116
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy plus standard care (medical and nursing care with scheduled pharmacologic pain intervention)
Trial: 28235116
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy plus standard care
Trial: 25612493
Drug: Rituximab (375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rituximab (375 mg/m²)
Trial: 19359536
Drug: Early invasive
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early invasive treatment strategy (EIS)
Trial: 19359536
Drug: Selective invasive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective invasive treatment strategy (SIS)
Trial: 15591013
Drug: L-carnitine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine (2 and 4 grams per day)
Trial: 6769159
Drug: Ketotifen (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketotifen (1 mg twice daily)
Trial: 2874780
Drug: Ketazolam once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketazolam once daily
Trial: 2874780
Drug: Divided doses
RxNorm normalized name: Aluminum Zirconium Trichlorohydrex Gly 20 g in 100 g TOPICAL STICK [Dividends]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Divided doses of ketazolam (from earlier study)
Trial: 27919356
Drug: niacin monotherapy
RxNorm normalized name: Niacin
DrugBank: Niacin (DB00627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: niacin monotherapy (N = 118)
Trial: 27919356
Drug: ezetimibe/simvastatin monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ezetimibe/simvastatin monotherapy (n = 155)
Trial: 27919356
Drug: ezetimibe/simvastatin (10/20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ezetimibe/simvastatin (10/20 mg) + niacin (to 2 g) (N = 279)
Trial: 24172024
Drug: Classroom-based cognitive-behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Classroom-based cognitive-behavioural therapy (CBT)
Trial: 15800981
Drug: LAM monotherapy
RxNorm normalized name: lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: LAM monotherapy (group A)
Trial: 15800981
Drug: Initial interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial interferon plus LAM treatment followed by LAM monotherapy (group B)
Trial: 12356387
Drug: Cerivastatin 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerivastatin 400 microg plus regular margarine 25 g
Trial: 12356387
Drug: Cerivastatin 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerivastatin 400 microg plus sterol‐ester margarine 25 g
Trial: 12356387
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus sterol‐ester margarine 25 g (2 g of plant sterol)